The High Court asked the government to issue a circular in this regard among the country's doctors within 30 days.
The health secretary and Bangladesh Medical and Dental Council's registrar will have to carry out the order. They will also have to inform the court about their progress within six weeks, the Dhaka Tribune reported.
The court yesterday also issued a ruling asking as to why the doctors should not be directed to mention generic names of medicines in prescriptions.
The Human Rights and Peace for Bangladesh (HRPB) moved the court with the writ petition on January 2, highlighting the difficulties faced by patients due to illegible prescriptions.
HRPB counsel Manzill Murshid said: "Sometimes even employees at drug stores fail to read prescriptions and give wrong medicines to the patients."
Some doctors specify medicines produced by particular companies. They write the brand names instead of the generic names, knowingly favouring certain companies.
Some media reports said there is a tacit understanding between these doctors and the pharmaceutical companies. The practice leads to patients buying expensive medicines where cheaper alternatives are available, or buy less potent medicines instead of more effective drugs.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
